Wolverine Trading’s Array Biopharma Inc ARRY Stock Holding History

Wolverine Trading’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,484	Closed	-$499K	–	5516
2019 Q1	$499K	Sell	20,484 -8,126	-28%	-$169K	﹤0.01%	2783
2018 Q4	$399K	Sell	28,610 -18,318	-39%	-$278K	﹤0.01%	2865
2018 Q3	$713K	Buy	+46,928	New	+$719K	﹤0.01%	2708
2018 Q1	–	Sell	-32,801	Closed	-$525K	–	6199
2017 Q4	$420K	Sell	32,801 -19,091	-37%	-$217K	﹤0.01%	3215
2017 Q3	$638K	Buy	51,892 +31,303	+152%	+$291K	﹤0.01%	2349
2017 Q2	$174K	Sell	20,589 -595	-3%	-$4.87K	﹤0.01%	3676
2017 Q1	$192K	Sell	21,184 -1,926	-8%	-$20.5K	﹤0.01%	3561
2016 Q4	$203K	Buy	23,110 +6,914	+43%	+$50.9K	﹤0.01%	3750
2016 Q3	$101K	Buy	+16,196	New	+$62.6K	﹤0.01%	4190

Other funds holding ARRY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wolverine Trading's ARRY Position: Q2 2019 in Review

Wolverine Trading sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 20,484 shares — an estimated $499K sold.

Wolverine Trading first reported a position in ARRY in Q3 2016 and held it in 9 quarters. The position peaked at $713K in Q3 2018. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

Wolverine Trading reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
Wolverine Trading sold 20,484 Array Biopharma Inc shares in Q2 2019, an estimated $499K.
Wolverine Trading first reported a position in Array Biopharma Inc in Q3 2016 and held it in 9 quarters.
Wolverine Trading's Array Biopharma Inc position peaked at $713K in Q3 2018.
319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.